Alienor Berges Vellay is an accomplished professional in clinical pharmacology with extensive experience in the pharmaceutical industry. Currently serving as Executive Director and Head of Clinical Pharmacology Modelling and Simulation for Respiratory & Immunology at GSK since August 2020, Alienor Berges Vellay previously held the position of Senior Clinical Pharmacology Scientist at AstraZeneca from January 2016 to July 2020. Earlier experience includes roles at GSK in clinical pharmacokinetic modelling and simulation from November 2006 to December 2015, and residency positions at Servier and ANSM Agence nationale de sécurité du médicament et des produits de santé, as well as Hospices Civils de Lyon. Educational qualifications include a Doctor of Pharmacy (PharmD) from Université Paris Cité and a four-year hospital residency in Pharmacy from Université Claude Bernard Lyon 1.
This person is not in any offices